SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Jun 19, 2019
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: June 19, 2019 · CIK: 0001585608 · Accession: 0000000000-19-010055
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232078
Letter
June 19, 2019 Lisa Conte Chief Executive Officer Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco, CA 94105 Re:Jaguar Health, Inc. Registration Statement on Form S-1 Filed June 12, 2019 File No. 333-232078 Dear Ms. Conte: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Sonia Bednarowski at 202-551-3666 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
June 19, 2019
Lisa Conte
Chief Executive Officer
Jaguar Health, Inc.
201 Mission Street, Suite 2375
San Francisco, CA 94105
Re:Jaguar Health, Inc.
Registration Statement on Form S-1
Filed June 12, 2019
File No. 333-232078
Dear Ms. Conte:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Sonia Bednarowski at 202-551-3666 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance